Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
18,751
Total Claims
$1.7M
Drug Cost
593
Beneficiaries
$2,836
Cost/Patient
Risk Score Breakdown 31/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+96%
Opioid rate vs peers
5.1% vs 2.6% avg
+166%
Cost per patient vs peers
$2,836 vs $1,068 avg
+49%
Brand preference vs peers
13.5% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
5.1%
Opioid Rate
949
Opioid Claims
$27K
Opioid Cost
17.5%
Long-Acting Rate
Brand vs Generic
Brand: 2,498 claims · $1.3M
Generic: 16,073 claims · $346K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 417 | $193K |
| Dulaglutide | 134 | $144K |
| Empagliflozin | 189 | $133K |
| Liraglutide | 51 | $63K |
| Rivaroxaban | 94 | $53K |
| Insulin Glargine,hum.Rec.Anlog | 100 | $52K |
| Tirzepatide | 40 | $49K |
| Insulin Degludec | 41 | $48K |
| Fluticasone/Umeclidin/Vilanter | 42 | $40K |
| Semaglutide | 31 | $39K |
| Cariprazine Hcl | 26 | $39K |
| Insulin Glargine,hum.Rec.Anlog | 16 | $36K |
| Sitagliptin Phosphate | 51 | $35K |
| Fluticasone/Vilanterol | 64 | $28K |
| Mirabegron | 62 | $25K |
Prescribing Profile
Patient Profile
72
Avg Age
67%
Female
1.72
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About